Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) Translocation

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 191-196

  Rubnitz, Jeffrey E ^a   Camitta, Bruce M ^a   Mahmoud, Hazem ^a   Raimondi, Susana C ^a   Carroll, Andrew J ^a   Borowitz, Micheal J ^a   Shuster, Jonathan J ^a   Link, Michael P ^a   Pullen, D Jeanette ^a   Downing, James R ^a   Behm, Frederick G ^a   Pui, Ching Hon ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHROMOSOME 11; CHROMOSOME 19; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; GENE; GENE FUSION; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; INFANT; LEUKEMIA REMISSION; MALE; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING;

EID: 0032894303     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.191     Document Type: Article

References (41)

1. Chen C-S, Sorensen PHB, Domer PH, et al: Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 81:2386-2393, 1993
2. Pui CH, Behm FG, Downing JR, et al: 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 12:909-915, 1994
3. Rubnitz JE, Link MP, Shuster JJ, et al: Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 84:570-573, 1994
4. Taki T, Ida K, Bessho F, et al: Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. Leukemia 10:1303-1307, 1996
5. Behm FG, Raimondi SC, Frestedt JL, et al: Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 87:2870-2877, 1996
6. Rubnitz JE, Behm FG, Pui C-H, et al: Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: Results of St. Jude Total Therapy Study XII. Leukemia 11:1201-1206, 1997
7. Cimino G, Lo Coco F, Biondi A, et al: ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 82:544-546, 1993
8. Cimino G, Rapanotti MC, Rivolta A, et al: Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. Leukemia 9:391-395, 1995
9. Pui CH, Behm FG, Raimondi SC, et al: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia [see comments]. N Engl J Med 321:136-142, 1989
10. Hunger SP, Tkachuk DC, Amylon MD, et al: HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities [see comments]. Blood 81:3197-3203, 1993
11. Super HJ, McCabe NR, Thirman MJ, et al: Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705-3711, 1993
12. Rubnitz JE, Behm FG, Downing JR: 11q23 Rearrangements in acute leukemia. Leukemia 10:74-82, 1996
13. Ziemin-van der Poel S, McCabe NR, Gill HJ, et al: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias [published erratum appears in Proc Natl Acad Sci U S A 89:4220, 1992]. Proc Natl Acad Sci U S A 88:10735-10739, 1991
14. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691-700, 1992
15. Gu Y, Nakamura T, Alder H, et al: The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF- 4 gene. Cell 71:701-708, 1992
16. Djabali M, Selleri L, Parry P, et al: A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukemias. Nat Genet 2:113-118, 1992
17. Domer PH, Fakharzadeh SS, Chen CS, et al: Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci U S A 90:7884-7888, 1993
18. Morrissey J, Tkachuk DC, Milatovich A, et al: A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Blood 81:1124-1131, 1993
19. Thirman MJ, Levitan DA, Kobayashi H, et al: Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23; p13.1) in acute myeloid leukemia. Proc Natl Acad Sci U S A 91:12110-12114, 1994
20. Mitani K, Kanda Y, Ogawa S, et al: Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23; p13.1) translocation. Blood 85:2017-2024, 1995
21. Akao Y, Seto M, Takahashi T, et al: Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations. Cancer Res 51:6708-6711, 1991
22. Rubnitz JE, Morrissey J, Savage PA, et al: ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 84:1747-1752, 1994
23. Lavau C, Szilvassy SJ, Slany R, et al: Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 16:4226-4237, 1997
24. So CW, Caldas C, Liu MM, et al: EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc Natl Acad Sci U S A 94:2563-2568, 1997
25. Rubnitz JE, Behm FG, Curcio-Brint AM, et al: Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. Blood 87:4804-4808, 1996
26. Huret JL, Brizard A, Slater R, et al: Cytogenetic heterogeneity in t(11;19) acute leukemia: Clinical, hematological and cytogenetic analyses of 48 patients - updated published cases and 16 new observations. Leukemia 7:152-160, 1993
27. Moorman AV, Hagemeijer A, Charrin C, et al: The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): A cytogenetic and clinical profile of 53 patients. Leukemia 12:805-810, 1998
28. Williams DL, Harris S, Williams KJ, et al: A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 13:239-257, 1984
29. Borowitz MJ, Shuster JJ, Civin CI, et al: Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A Pediatric Oncology Group study. J Clin Oncol 8:1389-1398, 1990
30. Crist WM, Carroll AJ, Shuster JJ, et al: Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A Pediatric Oncology Group study. Blood 76:117-122, 1990
31. Kaplan EL, Meier P: Non-parametric estimation for incomplete observations. Am Stat Assoc 53:457-481, 1958
32. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977
33. Pui CH, Frankel LS, Carroll AJ, et al: Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases [see comments]. Blood 77:440-447, 1991
34. Heerema NA, Arthur DC, Sather H, et al: Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: Impact of the 11q23 breakpoint on outcome - A Report of the Childrens Cancer Group. Blood 83:2274-2284, 1994
35. Pui C-H, Carroll AJ, Raimondi SC, et al: Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): An update. Blood 83:2384-2385, 1994
36. Johansson B, Moorman AV, Haas OA, et al: Hematologic malignancies with t(4;11)(q21;q23) - a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. Leukemia 12:779-787, 1998
37. Uckun FM, Steinherz PG, Sather H, et al: CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: A Children's Cancer Group study. Blood 88:4288-4295, 1996
38. Pui CH, Behm FG, Singh B, et al: Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 75:174-179, 1990
39. Shuster JJ, Falletta JM, Pullen DJ, et al: Prognostic factors in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 75:166-173, 1990
40. Pui CH, Rivera GK, Hancock ML, et al: Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 7:35-40, 1993
41. Pui CH, Behm FG, Crist WM: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82:343-362, 1993